OMIC

Singular Genomics Systems Inc

NASDAQ

Add Alert

OMIC

Singular Genomics Systems Inc

NASDAQ

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Monksdream PremiumMember

03/17/24 12:57 PM

Post #18

OMIC 10Q due 3/18

Michael TRed Free

11/07/23 2:53 PM

Post #17

Easy $ tomorrow...

DarkPool

11/07/23 11:49 AM

Post #16

Short boys. Ihub top contrerian has spoken.

TrendTrade2016 PremiumMember

11/07/23 10:59 AM

Post #15

OMIC NEXT BIO POPADOPPER

Monksdream PremiumMember

09/20/23 2:47 PM

Post #14

OMIC new 52 week low

Monksdream PremiumMember

09/18/23 1:20 PM

Post #13

OMIC new 52 week low

Monksdream PremiumMember

09/14/23 1:46 PM

Post #12

OMIC new 52 week low

Monksdream PremiumMember

09/06/23 3:04 PM

Post #11

OMIC new 52 weewk low

Monksdream PremiumMember

08/21/23 12:58 PM

Post #10

OMIC new 52 week low

StockLogistics Free

07/08/22 12:02 PM

Post #9

Fill the gaps at 3.24 and 3.00

StockLogistics Free

06/24/22 5:45 PM

Post #8

Gaps 3.00, 3.24, 3.64

StockLogistics Free

06/23/22 6:55 PM

Post #7

Gap at 3.00

StockLogistics Free

06/15/22 9:43 AM

Post #6

“4:30p ET 5/10/2022 - Benzinga
Singular Genomics Collaborates With NVIDIA To Deliver Market-Leading Next-Generation Sequencing And Analysis Speeds

Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced the company is collaborating with NVIDIA to validate and optimize the performance of the G4 Sequencing Platform with NVIDIA Clara Parabricks for secondary analysis including alignment and variant calling with over 50 tools for germline and somatic workflows.

This collaboration will enable access to Clara Parabricks for researchers and clinicians using Singular's G4 next-generation instrument, enabling users to run accelerated bioinformatics pipelines for key applications, such as whole genome sequencing, exome sequencing, RNA sequencing (RNA-Seq), and targeted gene panels. This solution will be seamlessly available to customers through Amazon Web Services Cloud implementation or on-premises servers that have NVIDIA GPUs.

"We are thrilled to bring NVIDIA's powerful analytical genomics workflows to Singular Genomics customers as a plug-and-play solution," said Jorge Velarde, Senior Vice President of Corporate Development and Strategy at Singular Genomics. "This collaboration further strengthens our industry-leading speed, providing researchers and clinicians with an opportunity to achieve significantly faster time to results. We look forward to working with NVIDIA and plan to disclose new data in the coming months that demonstrates the optimized performance through these platforms."

NVIDIA technology is used throughout genomics to accelerate traditional and deep learning analytics both within and off instrument for primary, secondary and tertiary genomic analysis. The G4 Sequencing Platform utilizes the NVIDIA RTX A6000 for AI-enabled basecalling. This announcement extends the collaboration to downstream workflows.

"Time to results is crucial across most NGS applications, and we believe that Clara Parabricks and NVIDIA's best-in-class GPU architecture combined with the speed and flexibility of the G4 Sequencing Platform is a natural fit," said George Vacek, Global Director of Genomics Alliances at NVIDIA. "The solution will be impactful to the genomics community and contribute to the advancement of science and medicine."

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.”

StockLogistics Free

06/14/22 1:35 PM

Post #5

Today: “Singular Genomics' management is scheduled to participate in a fireside chat Tuesday, June 14, 2022, at 4:00 p.m. Pacific Time / 7:00 p.m. Eastern Time. Investors and other interested parties are invited to listen to a live and recorded webcast of the presentation on the News & Events section of the company's investor relations website at https://investor.singulargenomics.com/news-events/event-calendar.”

StockLogistics Free

06/14/22 11:25 AM

Post #4

Reversal to trend higher around 12:30 today

StockLogistics Free

06/13/22 7:50 AM

Post #3

“11:29a ET 5/11/2022 - Dow Jones
Singular Genomics Systems Is Maintained at Buy by Goldman Sachs”

StockLogistics Free

06/10/22 7:29 PM

Post #2

“Cash, cash equivalents and short-term investments, excluding restricted cash, as of March 31, 2022 totaled 316.0 million.”

Outstanding shares: 70 million

316/70 = $4.51 per share with no multiple added and no value placed on the companies products, just based on cash owned by the company this stock is currently undervalued by almost a $1.50 today. Absolutely incredible.